Showing results (411-420 of 614) with videos related to
Sort By:
Pageof 62
Revue Medicale Suisse|September 30, 2011
[Do endothelin receptors antagonists have a place in the treatment of arterial hypertension?]V Forni, G Wuerzner, M Pruijm, et al.Revue Medicale Suisse|October 4, 2012
[Team-based care involving pharmacists and nurses to improve the management of hypertension]V Santschi, G Wuerzner, A Chiolero, et al.Annals of Emergency Medicine|December 1, 1986
Renal response to shockT J Burke, M Burnier, H Langberg, et al.Clinical Nephrology|September 19, 2009
Improvement in secondary hyperparathyroidism due to drug adherence monitoring in dialysis patientsM Pruijm, D Teta, G Halabi, et al.Lancet (London, England)|September 12, 1981
Antihypertensive effect of the new oral angiotensin converting enzyme inhibitor "MK-421"H Gavras, J Biollaz, B Waeber, et al.Journal of Clinical Pharmacology|March 1, 1986
Pharmacokinetics and pharmacodynamics of pentopril, a new angiotensin-converting-enzyme inhibitor in humansA Rakhit, M E Hurley, V Tipnis, et al.American Journal of Hypertension|December 1, 1992
Clinical experience with angiotensin II receptor antagonistsH R Brunner, Y Christen, A Munafo, et al.Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|July 1, 1992
Non-invasive determination of arterial diameter and distensibility by echo-tracking techniques in hypertensionD Hayoz, Y Tardy, F Perret, et al.Clinical and Experimental Pharmacology & Physiology|April 1, 1992
Inhibitory effect of neuropeptide Y on stimulated renin secretion of awake ratsJ F Aubert, P Walker, E Grouzmann, et al.Journal of Vascular Research|July 1, 1995
Intraluminal pressure modulates the magnitude and the frequency of induced vasomotion in rat arteriesH Achakri, N Stergiopulos, N Hoogerwerf, et al.Pageof 62